Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy
PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory